InfuSystem Holdings (INFU) Total Debt Growth (1y) (2011 - 2026)
InfuSystem Holdings (INFU) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 19.06% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -5.48% |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | -31.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.56% |
| Dec 31, 2025 | -17.76% |
| Sep 30, 2025 | -25.18% |
| Jun 30, 2025 | -22.88% |
| Mar 31, 2025 | -4.09% |
| Dec 31, 2024 | -18.00% |
| Sep 30, 2024 | -14.33% |
| Jun 30, 2024 | -5.46% |
| Mar 31, 2024 | -17.74% |
| Dec 31, 2023 | -12.23% |
| Sep 30, 2023 | -5.24% |
| Jun 30, 2023 | 7.28% |
| Mar 31, 2023 | 4.11% |
| Dec 31, 2022 | 0.18% |
| Sep 30, 2022 | 11.54% |
| Jun 30, 2022 | 3.78% |
| Mar 31, 2022 | 7.80% |
| Dec 31, 2021 | -14.70% |
| Sep 30, 2021 | -11.20% |
| Jun 30, 2021 | -20.57% |